Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.53 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.53 |
| ▸ | LDHA | P00338 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27926016 | 0.92 | CYP1A2 (0.60) | CYP1A2CYP2D6CYP2C19CYP1A1CYP1B1 | |
| SCHEMBL9749184 | 0.89 | CYP1A2 (0.57) | CYP1A2CYP2D6CYP2C19CYP1A1CYP1B1 | |
| SCHEMBL18892727 | 0.85 | MTNR1A (0.50) | CYP1A1CYP1B1LDHA | |
| SCHEMBL2992806 | 0.83 | KDM4E (0.56) | CYP1A2CYP2D6CYP2C19MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL11319694 | 0.82 | TDP1 (0.65) | CYP1A2MEN1KMT2AKDM4E | |
| SCHEMBL4889688 | 0.82 | TDP1 (0.65) | LDHAKDM4EALDH1A1GLAGAA | |
| Succinic Acid SCHEMBL9658515 | 0.82 | — | — | |
| SCHEMBL4269770 | 0.81 | CYP1A2 (0.53) | CYP1A2CYP2D6CYP2C19MEN1KMT2A | |
| SCHEMBL5997308 | 0.81 | CYP1A2 (0.53) | CYP1A2CYP2D6CYP2C19CYP1A1CYP1B1 | |
| SCHEMBL1218835 | 0.80 | TDP1 (0.67) | CYP1A2MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0201071-B1 | 2-SUBSTITUTED-1-NAPHTHOLS AS 5-LIPOXYGENASE INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-03-04 | — | — | EP | claimed |
| EP-2684863-B1 | IODOARENE DERIVATIVE, METHOD FOR PRODUCING OPTICALLY ACTIVE SPIROLACTONE COMPOUND USING SAME, AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLIZATION ADDUCT | NAT UNIV CORP NAGOYA UNIV (JP) | 2017-05-24 | — | — | EP | disclosed |
| EP-2684863-B1 | IODOARENE DERIVATIVE, METHOD FOR PRODUCING OPTICALLY ACTIVE SPIROLACTONE COMPOUND USING SAME, AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLIZATION ADDUCT | NAT UNIV CORP NAGOYA UNIV (JP) | 2017-05-24 | — | — | EP | disclosed |
| US-9018394-B2 | Method for producing aromatic compound having ring structure that includes nitrogen atom or oxygen atom | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-04-28 | — | — | US | disclosed |
| US-9018394-B2 | Method for producing aromatic compound having ring structure that includes nitrogen atom or oxygen atom | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-04-28 | — | — | US | disclosed |
| US-9018394-B2 | Method for producing aromatic compound having ring structure that includes nitrogen atom or oxygen atom | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-04-28 | — | — | US | disclosed |
| US-9000216-B2 | Iodoarene derivative, method for manufacturing optically active spirolactone compound by using the same, and method for manufacturing optically active cycloadduct | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-04-07 | — | — | US | disclosed |
| US-9000216-B2 | Iodoarene derivative, method for manufacturing optically active spirolactone compound by using the same, and method for manufacturing optically active cycloadduct | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-04-07 | — | — | US | disclosed |
| US-9000216-B2 | Iodoarene derivative, method for manufacturing optically active spirolactone compound by using the same, and method for manufacturing optically active cycloadduct | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-04-07 | — | — | US | disclosed |
| US-9000216-B2 | Iodoarene derivative, method for manufacturing optically active spirolactone compound by using the same, and method for manufacturing optically active cycloadduct | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-04-07 | — | — | US | disclosed |
| EP-2684863-A1 | IODOARENE DERIVATIVE, METHOD FOR PRODUCING OPTICALLY ACTIVE SPIROLACTONE COMPOUND USING SAME, AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLIZATION ADDUCT | National University Corporation Nagoya University (JP) | 2014-01-15 | — | — | EP | disclosed |
| EP-2684863-A1 | IODOARENE DERIVATIVE, METHOD FOR PRODUCING OPTICALLY ACTIVE SPIROLACTONE COMPOUND USING SAME, AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLIZATION ADDUCT | National University Corporation Nagoya University (JP) | 2014-01-15 | — | — | EP | disclosed |
| EP-2684863-A1 | IODOARENE DERIVATIVE, METHOD FOR PRODUCING OPTICALLY ACTIVE SPIROLACTONE COMPOUND USING SAME, AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLIZATION ADDUCT | National University Corporation Nagoya University (JP) | 2014-01-15 | — | — | EP | disclosed |
| US-20130338371-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND HAVING RING STRUCTURE THAT INCLUDES NITROGEN ATOM OR OXYGEN ATOM | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2013-12-19 | — | — | US | disclosed |
| US-20130338364-A1 | IODOARENE DERIVATIVE, METHOD FOR MANUFACTURING OPTICALLY ACTIVE SPIROLACTONE COMPOUND BY USING THE SAME, AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CYCLOADDUCT | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2013-12-19 | — | — | US | disclosed |
| US-20130338364-A1 | IODOARENE DERIVATIVE, METHOD FOR MANUFACTURING OPTICALLY ACTIVE SPIROLACTONE COMPOUND BY USING THE SAME, AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CYCLOADDUCT | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2013-12-19 | — | — | US | disclosed |
| CN-103415501-A | Iodoarene derivative, method for producing optically active spirolactone compound using same, and method for producing optically active cyclization adduct | UNIV NAGOYA NAT UNIV CORP | 2013-11-27 | — | — | CN | disclosed |
| CN-103415501-A | Iodoarene derivative, method for producing optically active spirolactone compound using same, and method for producing optically active cyclization adduct | UNIV NAGOYA NAT UNIV CORP | 2013-11-27 | — | — | CN | disclosed |
| WO-2012121248-A1 | IODOARENE DERIVATIVE, METHOD FOR PRODUCING OPTICALLY ACTIVE SPIROLACTONE COMPOUND USING SAME, AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLIZATION ADDUCT | 国立大学法人名古屋大学 (JP) | 2012-09-13 | — | — | WO | disclosed |
| WO-2012111449-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND HAVING RING STRUCTURE THAT INCLUDES NITROGEN ATOM OR OXYGEN ATOM | 国立大学法人名古屋大学 (JP) | 2012-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130338371-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND HAVING RING STRUCTURE THAT INCLUDES NITROGEN ATOM OR OXYGEN ATOM | TH, AOC3, NOX3 | CYP1A2 160/4885CYP2D6 708/4885CYP2C19 424/4885 |
| US-20130338364-A1 | IODOARENE DERIVATIVE, METHOD FOR MANUFACTURING OPTICALLY ACTIVE SPIROLACTONE COMPOUND BY USING THE SAME, AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CYCLOADDUCT | ADRA1A, HIRA, REN | CYP1A2 392/4885CYP2D6 289/4885CYP2C19 536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.